BICO Group AB Share Price

Equities

BICO

SE0013647385

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 08:59:38 26/04/2024 pm IST 5-day change 1st Jan Change
45.6 SEK +2.89% Intraday chart for BICO Group AB +3.07% -19.94%

Financials

Sales 2024 * 2.49B 227M 18.96B Sales 2025 * 2.89B 264M 22.02B Capitalization 3.22B 294M 24.53B
Net income 2024 * 14M 1.28M 107M Net income 2025 * 131M 11.97M 998M EV / Sales 2024 * 1.84 x
Net Debt 2024 * 1.36B 124M 10.37B Net Debt 2025 * 1.67B 152M 12.71B EV / Sales 2025 * 1.69 x
P/E ratio 2024 *
228 x
P/E ratio 2025 *
24.5 x
Employees 880
Yield 2024 *
-
Yield 2025 *
-
Free-Float 60.54%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.89%
1 week+3.07%
Current month-3.39%
1 month+5.90%
3 months-7.84%
6 months+67.34%
Current year-19.94%
More quotes
1 week
43.40
Extreme 43.4
48.00
1 month
41.46
Extreme 41.46
48.80
Current year
36.54
Extreme 36.54
61.12
1 year
23.38
Extreme 23.38
72.30
3 years
23.38
Extreme 23.38
630.00
5 years
23.38
Extreme 23.38
630.00
10 years
9.00
Extreme 9
630.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 20/11
Founder 35 01/15/01
Director of Finance/CFO 39 01/21/01
Members of the board TitleAgeSince
Chairman 79 26/22/26
Director/Board Member 61 01/23/01
Director/Board Member 68 18/19/18
More insiders
Date Price Change Volume
26/24/26 45.6 +2.89% 110,397
25/24/25 44.32 -0.67% 111,402
24/24/24 44.62 -6.50% 111,901
23/24/23 47.72 +1.62% 84,480
22/24/22 46.96 +6.15% 220,383

Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:59 pm IST

More quotes
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
45.6 SEK
Average target price
132.5 SEK
Spread / Average Target
+190.57%
Consensus

Annual profits - Rate of surprise